Globally, there is limited data on COVID-19 in pregnancy to inform recommendations for pregnant women and their care providers. This national surveillance project serves to better our understanding of the epidemiology and outcomes associated with COVID-19 in pregnancy and to thereby provide critical data to inform recommendations for pregnant women and their infants. A national approach, with regional leadership across Canada, is in progress with provincial/territorial data collection being combined for a national dataset of cases of COVID-19 in pregnancy. This project also lays the foundation for additional COVID-19 research through the establishment of a biospecimen repository from COVID-19 affected mother-infant pairs.
Coordinating centre lead: Dr. Deborah Money, Professor, Obstetrics & Gynaecology, Medicine, & SPPH Clinician Scientist, Women’s Health Research Institute
For further information please email the CANCOVID-Preg Research Manager Lucia Forward at email@example.comFollow @CANCOVIDPreg
As a sub-protocol of the Canadian Surveillance of COVID-19 in Pregnancy: Epidemiology, Maternal and Infant Outcomes, the Rapid Response Maternal-Infant Clinical and Biospecimen Access Platform, or Biorepository Study was developed to better understand the burden of COVID-19 on pregnancy. To do this, we have established a Biorepository of data and samples for future studies related to COVID-19 in pregnant populations.
Recruitment for the Biorepository Study is now closed.
For further information on the bio repository sub-study please reference our study page: Biorepository Sub Study
For further supporting information please reference the sections below
The National Protocol can be accessed here:
Data Collection Forms
McClymont E, Albert A, Alton GD, Boucoiran I, Castillo E, Fell DB, Kuret V, Poliquin V, Reeve T, Scott H, Sprague A, Carson G, Cassell K, Crane J, Elwood C, Joynt C, Murphy P, Murphy-Kaulbeck L, Saunders S, Shah P, Snelgrove J, van Schalkwyk J, Yudin MH, Money D. Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes. JAMA. 2022 May. doi:10.1001/jama.2022.5906
McClymont E, Abenhaim H, Albert A, Boucoiran I, Cassell K, Castillo E, Crane J, Elwood C, Fell DB, Joynt C, Kotaska A, Murphy PA, Murphy-Kaulbeck L, Poliquin V, Ryan S, Saunders S, Scott H, Shah P, Snelgrove J, van Schalkwyk J, Yudin MH, Money D. Canadian Surveillance of COVID-19 in Pregnancy (CANCOVID-Preg): A Rapidly Coordinated National Response Using Established Regional Infrastructures. J Obstet Gynaecol Can. 2021 Feb;43(2):165-166. doi: 10.1016/j.jogc.2020.10.005. PMID: 33546778.
McClymont E, Fell DB, Albert A, Alton GD, Barrett J, El-Chaar D, Harrold J, Krajden M, Lipsky N, Maan E, Malinowski AK, Othman M, Raeside A, Ray J, Roberts A, Ryan G, Sadarangani M, Sauve L, van Schalkwyk J, Shah P, Snelgrove JW, Sprague A, Ting J, Walker M, Whittle W, Williams C, Yudin MH, Zipursky JS, Abenhaim HA, Boucoiran I, Castillo E, Crane J, Elwood C, Joynt C, Kotaska A, Martel J, Murphy-Kaulbeck LC, Poliquin V, Ryan SR, Saunders S, Scott H, Money D. Canadian surveillance of COVID-19 in pregnancy: Epidemiology and maternal and infant outcomes. Am J Obstet Gynecol. 2020 Dec;223(6):969. doi:10.1016/j.ajog.2020.08.137.